BIOMAT Database Logo BIOMAT Database Logo

Effects of U-74389G, a novel 21-aminosteroid, on small intestinal ischemia and reperfusion injury in horses. 1996

N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Department of Surgical and Radiological Sciences, University of California, Davis 95616, USA.

OBJECTIVE To determine the effects of the 21-aminosteroid, U-74389G, on reperfusion of the equine jejunum, using total (TVO) and partial (PVO) vascular occlusion during the ischemic period. METHODS TVO: 16 healthy horses were randomly allotted to 3 groups-4 horses received the vehicle alone, 6 horses received a low dosage (3 mg/kg o body weight), and 6 horses a high dosage (10 mg/kg) of U-7438G. PVO: 10 healthy horses were randomly allotted to 2 groups--5 horses received the vehicle alone, and 5 horses received the low dosage (3 mg/kg) of U-74389G. METHODS TVO was induced for 1 hour followed by 2 hours of reperfusion. During PVO, blood flow was reduced to 20% of baseline for 2 hours, followed by 2 hours of reperfusion. For both models, either the vehicle alone or the drug was given 15 minutes prior to reperfusion. Samples were obtained before, during, and after ischemia for determination of myeloperoxidase (MPO) activity, malondealdehyde (MDA) concentration, concentration of conjugated dienes (PVO experiment only), and morphometric analysis. RESULTS TVO: tissue concentration of MDA and MPO activity were not altered in any group by ischemia or reperfusion. During ischemia, mucosal volume and surface area were reduced. After reperfusion, no further reduction occurred. After initial decrease in submucosal volume during ischemia, there was a significant increase after reperfusion in the vehicle-only group (P < 0.05). PVO: there were no alterations in the concentration of either MDA or conjugated dienes. There was significant increase in the activity of MPO during ischemia and reperfusion (P < 0.05). These effects were similar for the vehicle-only and drug groups. During ischemia, there was a significant decrease in mucosal surface area and volume (P < 0.05), that was continued during reperfusion for the vehicle-only (P < 0.05). Submucosal volume increased during ischemia and reperfusion. CONCLUSIONS Reduced blood flow during ischemia (PVO group) caused continued loss in mucosal volume and surface area during reperfusion. At the dosage given, the 21-aminosteroid, U-74389G, was not effective in preventing continued reduction in mucosal volume and surface area after restoration of blood supply in the horses subjected to reduced blood flow.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008641 Mesenteric Vascular Occlusion Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6) Mesenteric Vascular Occlusions,Occlusion, Mesenteric Vascular,Occlusions, Mesenteric Vascular,Vascular Occlusion, Mesenteric,Vascular Occlusions, Mesenteric
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D011281 Pregnatrienes Pregnane derivatives containing three double bonds in the ring structures.
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Beneficial effects of the 21-aminosteroid U 74389G on the ischemia-reperfusion damage in pig hearts.
October 1997, Journal of molecular and cellular cardiology,
N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Effects of dimethyl sulfoxide, allopurinol, 21-aminosteroid U-74389G, and manganese chloride on low-flow ischemia and reperfusion of the large colon in horses.
May 1995, American journal of veterinary research,
N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Protection of rat heart from ischaemia-reperfusion injury by the 21-aminosteroid U-74389G.
January 1996, Pharmacological research,
N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Effects of lazaroid U-74389G on intestinal ischemia and reperfusion injury in porcine experimental model.
January 2015, International journal of surgery (London, England),
N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Attenuation of hyperoxic lung injury by the 21-aminosteroid U-74389G.
May 1995, Journal of applied physiology (Bethesda, Md. : 1985),
N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Effect of U-74500A, a 21-aminosteroid on renal ischemia-reperfusion injury in rats.
March 2003, Renal failure,
N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
The 21-aminosteroid U-74389G protects the antioxidant enzymes in the ischemia/reperfusion-induced rat brain damage.
April 1994, European journal of pharmacology,
N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Radioprotective effects of the 21-aminosteroid U-74389G for stereotactic radiosurgery.
July 1997, Neurosurgery,
N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Therapeutic time window for the 21-aminosteroid, U-74389G, in global cerebral ischemia.
March 1996, Neurosurgery,
N J Vatistas, and J R Snyder, and S V Hildebrand, and F A Harmon, and M J Woliner, and S J Barry, and J Nieto, and P Henry, and L R Enos, and D Magliano, and S A Brown, and C Drake
Cardioprotective effects of Lazaroid U-74389G on ischemia-reperfusion injury in canine hearts.
April 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Copied contents to your clipboard!